B-Type Natriuretic Peptide / NT-proBNP
CardiacWhat is B-Type Natriuretic Peptide / NT-proBNP?
B-type natriuretic peptide (BNP) and its amino-terminal fragment NT-proBNP are cardiac neurohormones released primarily from ventricular cardiomyocytes in response to myocardial wall stress caused by volume overload or pressure overload. When the ventricles are stretched, the precursor molecule proBNP is cleaved into the biologically active BNP (32 amino acids) and the inactive NT-proBNP (76 amino acids). BNP acts on natriuretic peptide receptors to promote vasodilation, natriuresis (sodium excretion in urine), diuresis, and suppression of the renin-angiotensin-aldosterone system and sympathetic nervous system—all of which serve to reduce cardiac workload.
BNP and NT-proBNP are the cornerstone biomarkers for the diagnosis, risk stratification, and management of heart failure. They are particularly valuable in the emergency department for differentiating cardiac from pulmonary causes of acute dyspnea. NT-proBNP has a longer half-life (120 minutes vs. 20 minutes for BNP) and higher circulating concentrations, making it easier to measure, but it is more affected by renal function and age. Both markers have well-established age- and sex-specific cutoffs, and serial measurements are used to guide heart failure therapy and predict outcomes.
Why It Matters
BNP and NT-proBNP are among the most important biomarkers in cardiovascular medicine. A normal BNP or NT-proBNP level has a very high negative predictive value for heart failure—meaning if the level is normal, heart failure is very unlikely as the cause of a patient's symptoms. Elevated levels not only support the diagnosis of heart failure but also correlate with its severity (higher New York Heart Association class corresponds to higher levels). Serial monitoring helps clinicians titrate medications and detect worsening before clinical symptoms appear. These markers also provide prognostic information in acute coronary syndromes, pulmonary embolism, and sepsis.
Normal Reference Ranges
| Group | Range | Unit |
|---|---|---|
| BNP: Adults < 75 years | <100 | pg/mL |
| BNP: Adults ≥ 75 years | <200 | pg/mL |
| NT-proBNP: Adults < 75 years | <125 | pg/mL |
| NT-proBNP: Adults ≥ 75 years | <450 | pg/mL |
| NT-proBNP: Heart failure exclusion cutoff (acute dyspnea) | <300 | pg/mL |
Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.
What High BNP Levels Mean
Common Causes
- Heart failure (systolic or diastolic)
- Acute coronary syndromes
- Pulmonary embolism
- Atrial fibrillation or other arrhythmias
- Valvular heart disease (aortic stenosis, mitral regurgitation)
- Hypertensive crisis
- Pulmonary hypertension
- Chronic kidney disease (especially NT-proBNP)
- Sepsis and critical illness
- Cardiac amyloidosis
Possible Symptoms
- Shortness of breath (dyspnea), especially on exertion or when lying flat
- Swelling of the legs, ankles, or abdomen (edema)
- Fatigue and exercise intolerance
- Rapid or irregular heartbeat
- Persistent cough or wheezing
- Weight gain from fluid retention
- Difficulty sleeping due to breathlessness (orthopnea, PND)
What to do: Elevated BNP or NT-proBNP in the setting of dyspnea strongly suggests heart failure. Further evaluation should include echocardiography to assess cardiac structure and function, an electrocardiogram, chest X-ray, and renal function tests. Treatment of heart failure follows guideline-directed medical therapy including ACE inhibitors or ARNIs, beta-blockers, mineralocorticoid receptor antagonists, and SGLT2 inhibitors. Serial BNP/NT-proBNP monitoring helps guide therapy intensity and detect clinical deterioration early.
What Low BNP Levels Mean
Common Causes
- Obesity (BNP is paradoxically lower in obese patients due to increased clearance by adipose tissue natriuretic peptide receptors)
- Flash pulmonary edema with very acute onset (BNP may not have risen yet)
- Constrictive pericarditis (in some cases)
Possible Symptoms
- Low BNP itself does not cause symptoms
- A normal or low BNP in the right clinical context is reassuring against heart failure
What to do: Low BNP/NT-proBNP effectively rules out heart failure as the cause of symptoms in most clinical scenarios. In obese patients, be aware that BNP cutoffs may need to be adjusted downward, and a "normal" BNP does not completely exclude heart failure. If clinical suspicion remains high despite low natriuretic peptides, proceed with echocardiography.
When Is BNP Testing Recommended?
- When evaluating acute dyspnea in the emergency department to differentiate cardiac from pulmonary causes
- For diagnosis and staging of heart failure
- To guide and monitor heart failure treatment (serial measurements)
- As a prognostic marker in acute coronary syndromes or pulmonary embolism
- When screening high-risk patients for cardiac dysfunction (e.g., before cardiotoxic chemotherapy)
Frequently Asked Questions
Related Biomarkers
Want your BNP levels analyzed?
Upload your lab results for an instant AI-powered breakdown of all your biomarkers.
Upload Lab Results →Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.